By reactivating Notch1 in T-cells we aim to lower the threshold of T-cell activation to make tumor-suppressed T-cells more responsive to tumor antigen recognition when infiltrating the tumor microenvironment. The gene discussed is NOTCH1; the disease is neoplasm.